Skip to Main Content

Paper Details

Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff.
Clin Cancer Res
25
2014
Author NameAffiliation
Agnes C PaquetAuthors' Affiliations: Military Institute of Medicine, Warsaw Lublin Oncology Center, Lublin Bialystok Oncology Center, Bialystok Greater Poland Cancer Center, Poznan West Pomeranian Oncology Center, Szczecin Opole Oncology Center, Opole Warmia and Masuria Oncology Center, Olsztyn Bydgoszcz Oncology Center, Bydgoszcz Beskidy Oncology Center, Bielsko-Biala Medical University of Gdansk, Inc.
  • 1 - 1

Datasets